VCM
NVO

Virtue Capital Management’s Novo Nordisk NVO Stock Holding History

Virtue Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,175
Closed -$429K – 415
2025
Q1 		$429K Buy
6,175
+980
+19% +$80.9K 0.05% 294
2024
Q4 		$447K Sell
5,195
-1,886
-27% -$204K 0.09% 158
2024
Q3 		$843K Sell
7,081
-308
-4% -$41.1K 0.17% 99
2024
Q2 		$988K Buy
7,389
+1,398
+23% +$185K 0.17% 103
2024
Q1 		$752K Buy
5,991
+3,703
+162% +$441K 0.14% 142
2023
Q4 		$242K Buy
+2,288
New +$226K 0.05% 321

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Virtue Capital Management's NVO Position: Q2 2025 in Review

Virtue Capital Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 6,175 shares — an estimated $429K sold.

Virtue Capital Management first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $988K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Virtue Capital Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Virtue Capital Management sold 6,175 Novo Nordisk shares in Q2 2025, an estimated $429K.
  • Virtue Capital Management first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Virtue Capital Management's Novo Nordisk position peaked at $988K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Virtue Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.